Zadaxin synthetic thymosin alpha 1 regulatory update

SCLN received notice of allowance for a U.S. patent covering the use of its Zadaxin plus lamivudine and famciclovir to treat hepatitis B virus (HBV) infection. Zadaxin is marketed in Asia and is in Ph...